DR. VIVIEN KARL closes seven-figure seed round
Family office zwei.7 leads as Dieter von Holtzbrinck Ventures invests again.
The financing will support expansion into Germany’s major drugstore chains. That adds a broader retail channel to a business built primarily through direct consumer sales.
The company reports more than seventy thousand customers and revenue growth above 200% between 2024 and 2025. Its next challenge is translating that online demand into a lasting presence on store shelves.
Use of funds
Expand distribution into German drugstore chains